| Projects
|
|
|
The TRANSFOG project aims at the systematic identification and functional characterization
of novel cancer genes with high potential diagnostic and therapeutic value in breast,
colon and lung cancer. The TRANSFOG partner will bring together world recognised
competences and resources to reach the integrated research objectives.
TRANSFOG aims at the systematic identification and functional characterization of novel cancer genes
with high potential diagnostic and therapeutic value. The main ambition of this project is to re-establish
European leadership in the field of cancer genomics. To this aim, the project is integrating academic and
industrial cutting edge groups to develop a joint effort towards systematic identification and functional
characterization of novel cancer genes with high potential diagnostic and therapeutic value in breast, colon
and lung cancer. The project is based on the scientific excellence of the applicants, who have made major
recognized contributions to the field and on the construction of shared technological platforms.(...)
TRANSFOG brings together world-recognised competences and resources to reach the following, integrated research objectives:
1 Identification of novel cancer-related genes of high clinical-diagnostic potential,
with a specific focus on progression and metastasis of colon, breast, lung cancer.
2 Set-up of technologies for systematic cancer gene functional analysis and identification
of new molecular targets.
3 Systematic exploration of oncogenic/antioncogenic signalling pathways, epigenetic regulatory
mechanisms to generate a comprehensive overview of the alterations in signalling and regulatory
networks involved in cancer progression.
4 Development of tools for diagnostic validation of molecular signatures for cancers of high
population impact, such as colon, breast and lung. This enables translation into clinical
use of signatures obtained through the cancer-oriented genomic screenings performed by
the Partners.
5 Establishment of a shared bioinformatic platform for functional oncogenomics data
handling and standardization.
The TRANSFOG experimental pipeline consists of seven research components that
synergistically enable streamlined translation of large-scale genomic screenings into highimpact
contributions to cancer diagnosis and therapy.
|
|
|
|
|
-
1st European Association for Cancer Research (EACR) – Organisation of European Cancer Institutes (OECI)
Joint Training Course - “Molecular Pathology Approach to Cancer” recommended 13 European CME credits by ACOE
Amsterdam, March 7th – 9th 2011
Course Web Site
-
Bilateral Meeting Organisation of European Cancer Institutes - American Association of Cancer Institutes
“Organization of Comprehensiveness: comparison between OECI and AACI”
Amsterdam, June 16th 2011
-
Scientific Conference OECI 2011
“Organization of CCCs: the road map for innovation and the development of personalized cancer medicine”
Amsterdam, June 17th 2011
-
OECI General Assembly (restricted to OECI Members and Associated Members)
Amsterdam, June 18th 2011
-
FEBS Advanced Lecture Course "TRANSLATIONAL CANCER RESEARCH"
Hotel Porto Bay Falesia, Algarve
September 27 to October 4, 2011
Announcement
|
|
|
|
|
|